Home
About
FAQ
History (1)
Beta-2 adrenergic agonists: focus on safety and benefits versus risks.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Beta-2 adrenergic agonists: focus on safety and benefits versus risks.
Ortega VE, Peters SP. Beta-2 adrenergic agonists: focus on safety and benefits versus risks. Curr Opin Pharmacol. 2010 Jun; 10(3):246-53.
View in:
PubMed
subject areas
Adrenergic beta-Agonists
Anti-Asthmatic Agents
Asthma
Clinical Trials as Topic
Drug Therapy, Combination
Glucocorticoids
Humans
authors with profiles
Stephen Peters MD, PhD